AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitdc M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

FDC Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitdc M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo 50mg/500mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician supervision. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management, as lifestyle factors significantly influence glycemic control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; therefore, understanding hypoglycemia recognition and management is essential. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic disorders, or excessive alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Potential drug interactions exist; therefore, disclose all medications to your doctor to ensure treatment safety. Alcohol consumption should be minimized due to its hypoglycemic effects. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Sitdc M 50mg/500mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased. No rewriting is possible.

Uses of Sitdc M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Sitdc M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitdc M 50mg/500mg Tablet whole; do not crush, chew, or break it. Administer this medication with food.

Common Side effects of Sitdc M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitdc M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitdc M 50mg/500mg tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

How Sitdc M 50mg/500mg Tablet works:

Sitagliptin/metformin 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action promotes superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitdc M 50mg/500mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitdc M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitdc M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitdc M 50mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. The medication is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Sitdc M 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitdc M 50mg/500mg Tablet :

Should you forget to take a Sitdc M 50mg/500mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitdc M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitdc M 50mg/500mg Tablet

Sitdc M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitdc M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including impaired balance). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitdc M 50mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitdc M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Consuming alcohol with Sitdc M 50mg/500mg Tablet is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or heavy alcohol consumers. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitdc M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitdc M 50mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Sitdc M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and Sitdc M 50mg/500mg tablets is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this risk is higher in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitdc M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Sitdc M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitdc M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitdc M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitdc M 50mg/500mg tablets is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sitdc M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitdc M 50mg/500mg Tablet
188